Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Baer

Showing results (291-300 of 628) with videos related to

Pageof 63
Sort By:
Leukemia Research|December 21, 2007
Therapy-related myelodysplastic syndrome and acute myeloid leukemia following treatment of acute myeloid leukemia: possible role of cytarabineCecilia Arana-Yi, Annemarie W Block, Sheila N Sait, et al.
Leukemia Research|December 7, 2005
Chronic myeloid leukemia after treatment of lymphoid malignancies: response to imatinib mesylate and favorable outcomes in three patientsJeyanthi Ramanarayanan, Lauren M Dunford, Maria R Baer, et al.
Biochemical Pharmacology|December 25, 2012
The Pim kinase inhibitor SGI-1776 decreases cell surface expression of P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2) and drug transport by Pim-1-dependent and -independent mechanismsKarthika Natarajan, Jasjeet Bhullar, Suneet Shukla, et al.
Cancer Genetics and Cytogenetics|April 15, 2008
Acute promyelocytic leukemia after mitoxantrone therapy for multiple sclerosisBhuvaneswari Ramkumar, Manpreet K Chadha, Maurice Barcos, et al.
Cancer Research|March 14, 2001
A novel serine-dependent proteolytic activity is responsible for truncated signal transducer and activator of transcription proteins in acute myeloid leukemia blastsZ Xia, R R Salzler, D P Kunz, et al.
Blood|November 20, 2012
The constitutive androstane receptor is a novel therapeutic target facilitating cyclophosphamide-based treatment of hematopoietic malignanciesDuan Wang, Linhao Li, Hui Yang, et al.
Leukemia|June 23, 2004
Breast cancer resistance protein (BCRP/MXR/ABCG2) in acute myeloid leukemia: discordance between expression and functionA Suvannasankha, H Minderman, K L O'Loughlin, et al.
The Journal of the American Academy of Orthopaedic Surgeons|January 30, 2025
Preoperative Resilience as a Predictor of Postoperative Regret and Patient-Reported Outcomes in Total Knee ArthroplastyTimothy C Horan, Michael R Baer, Kishan S Shah, et al.
Blood|July 15, 1995
Does activation of the TAL1 gene occur in a majority of patients with T-cell acute lymphoblastic leukemia? A pediatric oncology group studyR O Bash, S Hall, C F Timmons, et al.
American Journal of Physical Medicine & Rehabilitation|August 30, 2019
Use of the Electrodiagnostic Entrustable Professional Activity for Competency Assessment in Physical Medicine and Rehabilitation Training ProgramsHeather R Baer, Aaron R Gilbert, Jeri E Forster, et al.
Pageof 63

Showing results (291-300 of 628) with videos related to

Sort By:
Pageof 63
Leukemia Research|December 21, 2007
Therapy-related myelodysplastic syndrome and acute myeloid leukemia following treatment of acute myeloid leukemia: possible role of cytarabineCecilia Arana-Yi, Annemarie W Block, Sheila N Sait, et al.
Leukemia Research|December 7, 2005
Chronic myeloid leukemia after treatment of lymphoid malignancies: response to imatinib mesylate and favorable outcomes in three patientsJeyanthi Ramanarayanan, Lauren M Dunford, Maria R Baer, et al.
Biochemical Pharmacology|December 25, 2012
The Pim kinase inhibitor SGI-1776 decreases cell surface expression of P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2) and drug transport by Pim-1-dependent and -independent mechanismsKarthika Natarajan, Jasjeet Bhullar, Suneet Shukla, et al.
Cancer Genetics and Cytogenetics|April 15, 2008
Acute promyelocytic leukemia after mitoxantrone therapy for multiple sclerosisBhuvaneswari Ramkumar, Manpreet K Chadha, Maurice Barcos, et al.
Cancer Research|March 14, 2001
A novel serine-dependent proteolytic activity is responsible for truncated signal transducer and activator of transcription proteins in acute myeloid leukemia blastsZ Xia, R R Salzler, D P Kunz, et al.
Blood|November 20, 2012
The constitutive androstane receptor is a novel therapeutic target facilitating cyclophosphamide-based treatment of hematopoietic malignanciesDuan Wang, Linhao Li, Hui Yang, et al.
Leukemia|June 23, 2004
Breast cancer resistance protein (BCRP/MXR/ABCG2) in acute myeloid leukemia: discordance between expression and functionA Suvannasankha, H Minderman, K L O'Loughlin, et al.
The Journal of the American Academy of Orthopaedic Surgeons|January 30, 2025
Preoperative Resilience as a Predictor of Postoperative Regret and Patient-Reported Outcomes in Total Knee ArthroplastyTimothy C Horan, Michael R Baer, Kishan S Shah, et al.
Blood|July 15, 1995
Does activation of the TAL1 gene occur in a majority of patients with T-cell acute lymphoblastic leukemia? A pediatric oncology group studyR O Bash, S Hall, C F Timmons, et al.
American Journal of Physical Medicine & Rehabilitation|August 30, 2019
Use of the Electrodiagnostic Entrustable Professional Activity for Competency Assessment in Physical Medicine and Rehabilitation Training ProgramsHeather R Baer, Aaron R Gilbert, Jeri E Forster, et al.
Pageof 63